Document is current
Any future updates will be listed below
-
Authors
Mazurek, Mercy H. https://orcid.org/0000-0002-4655-4266
Cahn, Bradley A.
Yuen, Matthew M.
Prabhat, Anjali M.
Chavva, Isha R.
Shah, Jill T.
Crawford, Anna L.
Welch, E. Brian
Rothberg, Jonathan
Sacolick, Laura
Poole, Michael
Wira, Charles
Matouk, Charles C. https://orcid.org/0000-0003-3234-9541
Ward, Adrienne
Timario, Nona
Leasure, Audrey
Beekman, Rachel
Peng, Teng J.
Witsch, Jens https://orcid.org/0000-0001-8924-851X
Antonios, Joseph P. https://orcid.org/0000-0002-5147-1377
Falcone, Guido J.
Gobeske, Kevin T.
Petersen, Nils
Schindler, Joseph
Sansing, Lauren
Gilmore, Emily J.
Hwang, David Y.
Kim, Jennifer A.
Malhotra, Ajay
Sze, Gordon
Rosen, Matthew S. https://orcid.org/0000-0002-7194-002X
Kimberly, W. Taylor https://orcid.org/0000-0002-2519-8530
Sheth, Kevin N. https://orcid.org/0000-0003-2003-5473
-
Funding
Funding for this research was provided by:
American Heart Association (17CSA3355004)
- License Information
-
More Information
Article History
Received: 19 August 2020
Accepted: 5 August 2021
First Online: 25 August 2021
Competing interests
: K.N.S. is the principal investigator. This study received support from the Collaborative Science Award from the American Heart Association (PIs: K.N.S., W.T.K., M.S.R.), National Institutes of Health Supplement Grant, and Hyperfine Research, Inc. research grant. W.T.K. receives grants from NIH and AHA; grants and personal fees from Biogen, Inc; grants and personal fees from NControl Therapeutics; has a patent pending that is licensed to NControl Therapeutics; holds equity in Woolsey Pharmaceuticals. M.S.R. is a co-founder of Hyperfine Research, Inc. J.R. is a co-founder of Hyperfine Research, Inc. E.B.W., L.S., and M.P. are research scientists and engineers at Hyperfine Research, Inc. All other authors declare no competing interests.
